Log in to save to my catalogue

The role of COPD in survival of NSCLC patients receiving immune checkpoint inhibitors: A meta-analys...

The role of COPD in survival of NSCLC patients receiving immune checkpoint inhibitors: A meta-analys...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_603ea255cb404f868bca3b1e301f8d98

The role of COPD in survival of NSCLC patients receiving immune checkpoint inhibitors: A meta-analysis

About this item

Full title

The role of COPD in survival of NSCLC patients receiving immune checkpoint inhibitors: A meta-analysis

Author / Creator

Publisher

Bosnia and Herzegovina: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina

Journal title

Biomolecules & biomedicine, 2025-05

Language

English

Formats

Publication information

Publisher

Bosnia and Herzegovina: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina

More information

Scope and Contents

Contents

The impact of chronic obstructive pulmonary disease (COPD) on the survival of patients with non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors (ICIs) remains unclear. Given the growing use of ICIs in NSCLC treatment and the high prevalence of COPD among these patients, understanding this relationship is essential. This meta-a...

Alternative Titles

Full title

The role of COPD in survival of NSCLC patients receiving immune checkpoint inhibitors: A meta-analysis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_603ea255cb404f868bca3b1e301f8d98

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_603ea255cb404f868bca3b1e301f8d98

Other Identifiers

ISSN

2831-0896,2831-090X

E-ISSN

2831-090X

DOI

10.17305/bb.2025.12355

How to access this item